title: Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking.
abstract: Baclofen has been reported in uncontrolled clinical studies to reduce craving for abused drugs and reduce their rewarding effects. The objective of the present study was to measure the acute effects of a single dose of baclofen on cigarette smoking, craving for nicotine, cigarette taste, and smoking satisfaction. Tobacco smokers (n = 16) who were not trying to quit received baclofen (20 mg) or placebo after overnight abstinence during two laboratory sessions in a within-subjects design. We measured the subjective effects of baclofen on mood and self-reported ratings of craving for nicotine, and on the number of cigarettes smoked of the subjects' preferred brand during a 3-h ad libitum smoking period. Baclofen did not change the number of cigarettes smoked by the subjects nor did it change ratings of nicotine craving. However, baclofen altered the sensory properties of smoked cigarettes (e.g., increasing ratings of 'harsh' and decreasing ratings of 'like cigarette's effects'). It also produced mild sedative-like subjective effects, such as increases in feeling 'relaxed'. Thus, although baclofen did not reduce cigarette craving or smoking in the present study, it did produce some mood-altering effects and changes in sensory aspects of smoking that may facilitate smoking cessation.
authors.affiliation: University of Chicago, Chicago, IL, USA.
authors.forename: M S
authors.initials: MS
authors.lastname: Cousins
authors.forename: H M
authors.initials: HM
authors.lastname: Stamat
authors.forename: H
authors.initials: H
authors.lastname: de Wit
mesh_terms: D000208:Acute Disease; D000328:Adult; D000339:Affect / Q000187:drug effects; D001418:Baclofen / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D018755:GABA Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009538:Nicotine / Q000009:adverse effects; D012650:Self Disclosure; D012720:Severity of Illness Index; D016540:Smoking Cessation; D000074606:Smoking Prevention; D013375:Substance Withdrawal Syndrome / Q000209:etiology; D011795:Surveys and Questionnaires; D014029:Tobacco Use Disorder / Q000534:rehabilitation*
chemical_list: D018755:GABA Agonists; D009538:Nicotine; D001418:Baclofen